<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01801540</url>
  </required_header>
  <id_info>
    <org_study_id>H-2-2010-095</org_study_id>
    <nct_id>NCT01801540</nct_id>
  </id_info>
  <brief_title>The Effects of L-arabinose in a Meal in Healthy Men</brief_title>
  <official_title>The Effects of L-arabinose in a Meal on Glucose Metabolism in Healthy Men</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Copenhagen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the effect of a meal containing different doses
      of L-arabinose, on the intestinal sucrase activity after intake We measure this by measuring
      the glucose, insulin and c-peptide after meals. Other measurements are made (glucagon and
      GLP-1) to explain the correlations.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2010</start_date>
  <completion_date type="Actual">March 2011</completion_date>
  <primary_completion_date type="Actual">March 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glucose</measure>
    <time_frame>-15, 0, 15, 30, 45, 60, 90, 120, 180 min</time_frame>
    <description>Level of glucose over time, The AUC, the peak value and time to peak</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Insulin</measure>
    <time_frame>-15, 0, 15, 30, 45, 60, 90, 120, 180 min</time_frame>
    <description>Level of insulin over time, the AUC, the peak value and time to peak</description>
  </primary_outcome>
  <primary_outcome>
    <measure>C-peptide</measure>
    <time_frame>-15, 0, 15, 30, 45, 60, 90, 120, 180 min</time_frame>
    <description>Level of c-peptide over time, The AUC, the peak value and time to peak</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Glucagon</measure>
    <time_frame>-15, 0, 15, 30, 45, 60, 90, 120, 180 min</time_frame>
    <description>Level of glucagon over time, The AUC, the peak value and time to peak</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GLP-1</measure>
    <time_frame>-15, 0, 15, 30, 45, 60, 90, 120, 180 min</time_frame>
    <description>Level of GLP-1 over time, The AUC, the peak value and time to peak</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">17</enrollment>
  <condition>Glucose Metabolism</condition>
  <arm_group>
    <arm_group_label>0% arabinose meal sucrose/starch</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A meal containing a bon with butter and marmalade, a cup cake, The and water</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5 % arabinose meal sucrose/starch</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>A meal containing a bon with butter and marmalade, a cup cake, The and water</description>
  </arm_group>
  <arm_group>
    <arm_group_label>10 % arabinose meal sucrose/starch</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>A meal containing a bon with butter and marmalade, a cup cake, The and water</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0 % arabinose meal Starch</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>A meal containing two bons with butter and cheese, The and water</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5 % arabinose meal starch</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>A meal containing two bons with butter and cheese, The and water</description>
  </arm_group>
  <arm_group>
    <arm_group_label>10 % arabinose meal starch</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>A meal containing two bons with butter and cheese, The and water</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>L-arabinose - effect on glucose metabolism</intervention_name>
    <description>L-arabinose is mixed into the dough of the buns and cup cakes</description>
    <arm_group_label>0% arabinose meal sucrose/starch</arm_group_label>
    <arm_group_label>5 % arabinose meal sucrose/starch</arm_group_label>
    <arm_group_label>10 % arabinose meal sucrose/starch</arm_group_label>
    <arm_group_label>0 % arabinose meal Starch</arm_group_label>
    <arm_group_label>5 % arabinose meal starch</arm_group_label>
    <arm_group_label>10 % arabinose meal starch</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy male

          -  normal weight (BMI 18,5-25 kg/m2)

          -  18-30 years of age

        Exclusion Criteria:

          -  Not healthy,including those with diabetes Mellitus, high bloodpressure, dyslipidemia
             or a infectious diseases (hepatitis or HIV), gastrointestinal disorders

          -  Central adipositas (defined as waist circumference &gt; 94 cm for european men)

          -  Daily intake of vitamins and minerals, 3 months before the trail starts and during the
             trail.

          -  elevated alcoholcunsumption(&gt; 21 units af alcohol pr. week)

          -  take medicine

          -  Elite athlete with intensive training

          -  given bloddonation within the last 3 months

          -  smoking
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jens Rikardt Andersen, MD, lector</last_name>
    <role>Study Director</role>
    <affiliation>Unit of Nutrition 5711, Rigshospitalet, Blegdamsvej 9, 2100 København Ø</affiliation>
  </overall_official>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 27, 2013</study_first_submitted>
  <study_first_submitted_qc>February 27, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 28, 2013</study_first_posted>
  <last_update_submitted>February 27, 2013</last_update_submitted>
  <last_update_submitted_qc>February 27, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 28, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Copenhagen</investigator_affiliation>
    <investigator_full_name>AAstrup</investigator_full_name>
    <investigator_title>Dr.Med.Sci./Ph.D.</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

